AI Article Synopsis
- * A notable test emerging in Europe uses machine learning to analyze microRNAs from a study involving 200 patients suspected of having endometriosis.
- * Caution is advised against using this test outside of research settings, as several unanswered questions remain regarding its validity and application.
Article Abstract
A reliable non-invasive biomarker for endometriosis is highly likely in the coming years. In the lead-up to this, clinicians need to be aware of commercially available tests as they become accessible, be aware of the level of evidence to support them and be prepared to counsel and manage patients who present with the results of such tests. One such test gaining popularity in Europe was developed using a machine-based learning algorithm to analyse thousands of microRNAs based on a 200-patient cohort with suspected endometriosis in France. We explore the background science for this commercially available test; outline the questions that remain to be answered; and caution against its use outside of a research setting.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ajo.13765 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!